Pelle Simpson is Senior Scientist at Enveda Biosciences and has a background in chromatography and mass spectrometry, initially focusing on natural products drug discovery and cell signaling proteomics at the University of Amsterdam. He expanded his research in proteomics at the University of Colorado, Boulder, where he also developed interests in 3D printing, machining, and programming for lab automation. Since joining Enveda Biosciences in 2021, he has leveraged these skills to develop custom hardware and software to enable the company’s mass spectrometry and high-throughput screening efforts.
Metabolomics Meets Machine Learning: The Future of Nature-Inspired Drug Discovery
March 29th 2024Researchers at Enveda Biosciences are transforming nature into new medicines with their artificial intelligence (AI)-enabled industrial-scale drug discovery platform incorporating tandem mass spectrometry (MS/MS).